1.A Case of Conjunctival Intraepithelial Neoplasia(CIN) Misdiagnosed as Atypical Pterygium.
Do Hyung LEE ; Jeung Hun JANG ; Jae Yoon OH ; Jae Suk KIM
Journal of the Korean Ophthalmological Society 2000;41(12):2750-2754
No Abstract Available.
Pterygium*
2.Production of monoclona antibody to infectious bursal disease virus as a diagnostic methods.
Hyung Kwan JANG ; Jai Hong KIM ; Chang Seon SONG ; Soon Jae KIM ; Tae Jong KIM
Journal of the Korean Society of Virology 1993;23(2):171-182
No abstract available.
Infectious bursal disease virus*
3.Three cases of sphenoethmoidal mucoceles.
Mi Gyeong YANG ; Jae Yeong CHOI ; Jang Su SUH ; Hyung Chul LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(5):1069-1073
No abstract available.
Mucocele*
4.Traumatic Posterior Dislocation of the Sternoclavicular Joint: A case Report
Jang Sung LEE ; Byung Guk KIM ; Hyung Joo KIM ; Seung Ki JEONG ; Seung Jae SON
The Journal of the Korean Orthopaedic Association 1990;25(2):579-583
Dislocation of the clavicle at its sternal end is relatively rare, as compared with acromioclavicular dislocation. Among them, the posterior dislocation of the sternoclavicular joint was extremely rare. So, not more than fifty cases had been reported in the literature. Of these three main typesanterior, superior, and posterior-the anterior one is by far the most common. Most authors have stressed the difficulty in confirming the diagnosis with routine radiographs. We experienced a case of traumatic posterior dislocation of the sternoclavicular joint treated successfully by manipulative reduction. So, we report it with review of literature.
Clavicle
;
Diagnosis
;
Dislocations
;
Sternoclavicular Joint
5.Synovial chondromatosis of the ankle: two cases report.
Jae Yo HYUN ; Sung Bae KIM ; Eui Keum LEE ; Se Young JANG ; Jae Hyung LEE ; In Kue KANG
The Journal of the Korean Orthopaedic Association 1992;27(3):852-856
No abstract available.
Ankle*
;
Chondromatosis, Synovial*
6.Prognostic Value and Optimal Sampling Time of S-100B Protein for Outcome Prediction in Cardiac Arrest Patients Treated with Therapeutic Hypothermia.
Hyung Seok KIM ; Ho Sung JUNG ; Yong Su LIM ; Jae Hyug WOO ; Jae Ho JANG ; Jee Yong JANG ; Hyuk Jun YANG
Korean Journal of Critical Care Medicine 2014;29(4):304-312
BACKGROUND: The aim of this study was to determine the prognostic value and optimal sampling time of serum S-100B protein for the prediction of poor neurological outcomes in post-cardiac arrest (CA) patients treated with therapeutic hypothermia (TH). METHODS: We prospectively measured serum S100 calcium binding protein beta subunit (S-100B protein) levels 12 times (0-96 hours) after the return of spontaneous circulation (ROSC). The patients were classified into two groups based on cerebral performance category (CPC): the good neurological outcome group (CPC 1-2 at 6 months) and the poor neurological outcome group (CPC 3-5). We compared serial changes and serum S-100B protein levels at each time point between the two groups and performed receiver operating characteristic curve analysis for the prediction of poor neurological outcomes. RESULTS: A total of 40 patients were enrolled in the study. S-100B protein levels peaked at ROSC (0 hour), decreased rapidly to 6 hours and maintained a similar level thereafter. Serum S-100B protein levels in the poor CPC group (n = 22) were significantly higher than in the good CPC group (n = 18) at all time points after ROSC except at 4 hours. The time points with highest area under curve were 24 (0.829) and 36 (0.837) hours. The cut-off value, the sensitivity (24/36 hours) and specificity (24/36 hours) for the prediction of poor CPC at 24 and 48 hours were 0.221/0.249 ug/L, 75/65% and 82.4/94.1%, respectively. CONCLUSIONS: Serum S-100B protein was an early and useful marker for the prediction of poor neurological outcomes in post-CA patients treated with TH and the optimal sampling times were 24 and 36 hours after ROSC.
Area Under Curve
;
Heart Arrest*
;
Humans
;
Hypothermia*
;
Prospective Studies
;
ROC Curve
;
S100 Calcium Binding Protein beta Subunit*
;
Sensitivity and Specificity
7.Soft tissue osteochondroma: a case report.
Jae Yo HYUN ; Seong Bae KIM ; Seung Ki JUNG ; Se Young JANG ; Jae Hyung LEE ; Seung Jae SON ; Ick Soo KIM
The Journal of the Korean Orthopaedic Association 1992;27(3):830-833
No abstract available.
Osteochondroma*
8.Prediction of Pulmonary Arterial Pressure by Pulsed Doppler Echocardiography.
Jang Seong CHAE ; Chong Sang KIM ; Jae Hyung KIM ; Kyu Bo CHOI ; Soon Jo HONG ; Hak Joong KIM
Korean Circulation Journal 1987;17(1):113-121
Noninvasive prediction of pulmonary arterial pressure is of paramount importance in heart disease. To estimate pulmonary arterial pressure, several echocardiographic techniques, including abnormal pulmonary valve motion, prolongation of RV preejection period/RV ejection time ratio and contrast echocardiography have been proposed. Recently Doppler echocardiography has been known to detect intracardiac blood quantitatively. For assessment of the benefit of several indices by Pulsed Doppler echocardiography for mean pulmonary arterial pressure, 22 patients(mean pulmonary pressure> or =20mmHg; 11, <20mmHg; 11) were compared with the mean pulmonary arterial pressure by cardiac catheterization. In comparison of mean pulmonary arterial pressure(MPAP); 1) Right preejection period / RV ejection time RPEP/RVET;r=0.278 2) Right preejection period / Acceleration time RPEP/AT : r=0.654 3) Acceleration time(AT) AT=-1.55(MPAP)+154.37(r=-0.763) AT=-92.99(log MPAP)+239.41(r=-0.752) AT is less than 105 msec in 9 or 11 pulmonary hypertension and one of 11 normal individual. 4) Acceleration time/ RV ejection time AT/RVET=-136.36(MPAP)+83.31(r=-0.817) AT/RVET=-0.29(log MPAP)+0.81(r=-0.803) 5) (Right preejection period+Decceleration time) / AT (RPEP+DT)/AT=9.6(MPAP)-0.16(r=0.806) (RPEP+DT)/AT=3.86(log MPAP)-2.46(r=0.789) In conclusion AT/RVET, (RPEP+DT)/AT and Acceleration time of 105 msec are valuable indices to estimate mean pulmonary arterial pressure by Pulsed Doppler echocardiogram.
Acceleration
;
Arterial Pressure*
;
Cardiac Catheterization
;
Cardiac Catheters
;
Echocardiography
;
Echocardiography, Doppler
;
Echocardiography, Doppler, Pulsed*
;
Heart Diseases
;
Hypertension, Pulmonary
;
Pulmonary Valve
9.Measurement of Velocity of Upper Eyelid Movement Using Video Camera in Patients with Blepharoptosis.
Sang Yeul LEE ; Tae Hyung KIM ; Jae Woo JANG ; Helen LEW
Journal of the Korean Ophthalmological Society 1999;40(6):1451-1458
Levator function test is one of the most useful methods of diagnosis and evaluation of blepharoptosis. Because levator function test is more difficult to measure and unreliable in children or uncooperated patients, new method evaluating blepharoptosis is needed in these patients. Therefore, we measured lid movement velocity and the correlation between levator palpe-bral muscle function and lid motility velocity was evaluated. We videotaped the eyelid movements using videocamera in 66 eyes, 33 patients before operation, and analyzed the eyelid movement velocity and com-pared the eyelid movement velocity with levator palpebral muscle function. Levator palpebral muscle function was directly related to the mean velocity of eye opening, correlation coefficiency being 0.687(p<0.05). Therefore, we conclude that the mean velocity of eye opening using video camera can be useful for evaluation of blepharoptosis in uncooperated patients.
Blepharoptosis*
;
Child
;
Diagnosis
;
Eyelids*
;
Humans
10.Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary Bladder.
Hoon JANG ; Wun Jae KIM ; Hyung Lae LEE
Korean Journal of Urology 2004;45(6):530-534
PURPOSE: Recent studies have supported the important role of cyclooxygenase-2 (COX-2) in various cancers derived from epithelial cell, such as the gastrointestinal tract, breast, head, and neck. In this case-control study, the clinical significance of COX-2 expression was investigated in patients with transitional cell carcinoma (TCC) of the urinary bladder. MATERIALS AND METHODS: Tumor samples were obtained from 43 bladders of TCC patients undergoing either transurethral resection (TUR) or radical cystectomy. Normal bladder tissues were also acquired from 50 age- and sex-matched patients without bladder cancer, mainly in benign prostatic hyperplasia. Paraffin sections were assessed with immunohistochemistry using the anti-human COX-2 monoclonal antibody. COX-2 expression was graded on a scale of 0-3+ according to the intensity and rate of immunohistochemical staining. RESULTS: COX-2 was expressed in 42 of 43 (97.7%) in human TCCs of the urinary bladder but not in all normal bladder tissues (p<0.001). COX-2 expression was significantly higher in invasive tumors than in superficial TCCs (p=0.038). Additionally, COX-2 expression had a significant correlation with the tumor stage (p=0.016), but not with the tumor grade (p=0.169). CONCLUSIONS: This study showed that COX-2 was expressed in human TCCs of the urinary bladder, and its expression was highly correlated to the tumor stage. These results support the possibility that COX-2 might play an important role in tumorigenesis and invasiveness of human TCCs of the urinary bladder.
Breast
;
Carcinogenesis
;
Carcinoma, Transitional Cell*
;
Case-Control Studies
;
Cyclooxygenase 2*
;
Cystectomy
;
Epithelial Cells
;
Gastrointestinal Tract
;
Head
;
Humans*
;
Immunohistochemistry
;
Neck
;
Paraffin
;
Prostatic Hyperplasia
;
Urinary Bladder Neoplasms
;
Urinary Bladder*